Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fibrinolytics and defibrinating agents].

D Vergoz

    Phlebologie
    |January 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Therapeutic fibrinolysis is the main treatment for dissolving blood clots, but its use is limited by bleeding risks and complex lab tests. Newer methods improve accessibility but reduce effectiveness, necessitating careful consideration of treatment indications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Some surgical aspects of portal hypertension].

    Pathologie et biologie·2014
    Same author

    Overall study of the in vitro plasma clotting system in an invertebrate, Liocarcinus puber (Crustacea Decapoda): considerations on the structure of the Crustacea plasma fibrinogen in relation to evolution.

    Journal of invertebrate pathology·1989
    Same author

    [Thrombogenic abnormalities of hemostasis. Practical implications].

    Phlebologie·1985
    Same author

    [Antithrombin III deficiency induced by heparin and constitutional protein C deficiency. Apropos of a case].

    Phlebologie·1985
    Same author

    [A case of dysfibrinogenemia complicated by hemorrhage and thrombosis].

    Phlebologie·1985
    Same author

    Immunoglobulin G antibodies to lymphadenopathy-associated virus in differently treated French and Belgian hemophiliacs.

    Annals of internal medicine·1985
    Same journal

    [Effect of veinotonyl 75 on the capillary permeability test using technetium albumin in cyclic orthostatic edemas].

    Phlebologie·1993
    Same journal

    [Variceal thromboses, their ambulatory treatment].

    Phlebologie·1993
    Same journal

    [Endoscopic treatment of perforating veins--current data].

    Phlebologie·1993
    Same journal

    [Program for the development and storing of images].

    Phlebologie·1993
    Same journal

    [Neutrophil activation in experimental venous hypertension].

    Phlebologie·1993
    Same journal

    [Is duplex echography mandatory in cases of deep venous insufficiency?].

    Phlebologie·1993
    See all related articles

    Area of Science:

    • Cardiovascular Medicine
    • Hematology
    • Pharmacology

    Context:

    • Thrombotic disorders pose significant health risks.
    • Therapeutic fibrinolysis offers a direct method for thrombus dissolution.
    • Limited clinical adoption due to hemorrhage risk and specialized monitoring.

    Purpose:

    • To review the current status and challenges of therapeutic fibrinolysis.
    • To discuss advancements in fibrinolytic therapy administration.
    • To evaluate the balance between efficacy and safety in clinical practice.

    Summary:

    • Therapeutic fibrinolysis is the primary approach for treating thromboses.
    • Historical limitations include high hemorrhage risk and complex laboratory controls.
    • Recent administration methods enhance accessibility but may decrease efficacy.

    Related Experiment Videos

  • Clinical results are satisfactory in some cases but remain limited.

    • Impact:

    • Highlights the need for improved fibrinolytic strategies.
    • Suggests that current indications for fibrinolysis should not be overly restricted.
    • Emphasizes the ongoing challenge of optimizing thrombolytic therapy for broader clinical application.